Home Dental Radiology Magnetic resonance imaging of methotrexate-related lymphoproliferative disorder with a chief complaint of oral symptoms

Magnetic resonance imaging of methotrexate-related lymphoproliferative disorder with a chief complaint of oral symptoms

by adminjay


  • Ishida M, Hodohara K, Yoshii M, Okuno H, Horinouchi A, Nakanishi R, et al. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis. Int J Clin Exp Pathol. 2013;6:2237–41.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Romão VC, Canhão H, Fonseca JE. Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic dmards? BMC Med. 2013;11:17. https://doi.org/10.1186/1741-7015-11-17.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Horie N, Kawano R, Kaneko T, Shimoyama T. Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis. Aust Dent J. 2015;60:408–11. https://doi.org/10.1111/adj.12235.

    Article 
    PubMed 

    Google Scholar
     

  • Sce HN, Jaffe ES, Pileri SA, Stein H, Thiele J, Swerdlow VJW. WHO classif tumors hematopoietic lymphoid tissues. Lyon: IRAC Publication; 2008.


    Google Scholar
     

  • Salloum E, Cooper DL, Howe G, Lacy J, Tallini G, Crouch J, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996;14:1943–9. https://doi.org/10.1200/JCO.1996.14.6.1943.

    Article 
    PubMed 

    Google Scholar
     

  • Furukawa S, Oobu K, Moriyama M, Kawano S, Sako S, Hayashida JN, et al. Oral methotrexate-related lymphoproliferative disease presenting with severe osteonecrosis of the jaw: a case report and literature review. Intern Med. 2018;57:575–81. https://doi.org/10.2169/internalmedicine.8946-17.

    Article 
    PubMed 

    Google Scholar
     

  • Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991;18:1741–3.

    PubMed 

    Google Scholar
     

  • Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J, et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 2002;99:3909–15. https://doi.org/10.1182/blood.v99.11.3909.

    Article 
    PubMed 

    Google Scholar
     

  • Kamel OW, van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein–Barr virus and other features associated with immunosuppression. Hum Pathol. 1994;25:638–43. https://doi.org/10.1016/0046-8177(94)90295-x.

    Article 
    PubMed 

    Google Scholar
     

  • Hoshida Y, Xu JX, Fujita S, Nakamichi I, Ikeda J, Tomita Y, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007;34:322–31.

    PubMed 

    Google Scholar
     

  • Hashimoto A, Chiba N, Tsuno H, Komiya A, Furukawa H, Matsui T, et al. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population. J Rheumatol. 2015;42:564–71. https://doi.org/10.3899/jrheum.140533.

    Article 
    PubMed 

    Google Scholar
     

  • Kojima M, Itoh H, Hirabayashi K, Igarashi S, Tamaki Y, Murayama K, et al. Methtrexate-associated lymphoproliferative disorders. a clinicopathological study of 13 Japanese cases. Pathol Res Pract. 2006;202:679–85.

    Article 

    Google Scholar
     

  • Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, et al. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013;91:20–8. https://doi.org/10.1111/ejh.12116.

    Article 
    PubMed 

    Google Scholar
     

  • Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol. 1997;15:405–31. https://doi.org/10.1146/annurev.immunol.15.1.405.

    Article 
    PubMed 

    Google Scholar
     

  • Johnston A, Gudjonsson JE, Sigmundsdottir H, Ludviksson BR, Valdimarsson H. The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. Clin Immunol. 2005;114:154–63. https://doi.org/10.1016/j.clim.2004.09.001.

    Article 
    PubMed 

    Google Scholar
     

  • Feng WH, Cohen JI, Fischer S, Li L, Sneller M, Goldbach-Mansky R, et al. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst. 2004;96:1691–702. https://doi.org/10.1093/jnci/djh313.

    Article 
    PubMed 

    Google Scholar
     

  • Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin’s disease. a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol. 1991;139:1259–65.

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Niitsu N, Okamoto M, Nakamine H, Hirano M. Clinicopathologic features and treatment outcome of primary breast diffuse large B-cell lymphoma. Leuk Res. 2008;32:1837–41. https://doi.org/10.1016/j.leukres.2008.04.005.

    Article 
    PubMed 

    Google Scholar
     

  • Rizzi R, Curci P, Delia M, Rinaldi E, Chiefa A, Specchia G, et al. Spontaneous remission of “methotrexate-associated lymphoproliferative disorders” after discontinuation of immunosuppressive treatment for autoimmune disease. review of the literature. medical oncology (Northwood, London, England). Med Oncol. 2009;26:1–9.

    Article 

    Google Scholar
     

  • Ichikawa Y, Sumi M, Sasaki M, Sumi T, Nakamura T. Efficacy of diffusion-weighted imaging for the differentiation between lymphomas and carcinomas of the nasopharynx and oropharynx: correlations of apparent diffusion coefficients and histologic features. AJNR Am J Neuroradiol. 2012;33:761–6. https://doi.org/10.3174/ajnr.A2834.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Asaumi J, Yanagi Y, Hisatomi M, Matsuzaki H, Konouchi H, Kishi K. The value of dynamic contrast-enhanced MRI in diagnosis of malignant lymphoma of the head and neck. Eur J Radiol. 2003;48:183–7. https://doi.org/10.1016/S0720-048X(02)00347-9.

    Article 
    PubMed 

    Google Scholar
     

  • Yabuuchi H, Fukuya T, Tajima T, Hachitanda Y, Tomita K, Koga M. Salivary gland tumors: diagnostic value of gadolinium-enhanced dynamic MR imaging with histopathologic correlation. Radiology. 2003;226:345–54. https://doi.org/10.1148/radiol.2262011486.

    Article 
    PubMed 

    Google Scholar
     

  • Takanashi S, Nakazato T, Aisa Y, Ito C, Arakaki H, Osada Y, et al. The prognostic value of positron emission tomography/computed tomography in rheumatoid arthritis patients with methotrexate-associated lymphoproliferative disorders. Ann Hematol. 2018;97:1611–8. https://doi.org/10.1007/s00277-018-3327-4.

    Article 
    PubMed 

    Google Scholar
     

  • Watanabe S, Manabe O, Hirata K, Oyama-Manabe N, Hattori N, Kikuchi Y, et al. The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD). BMC Cancer. 2016;16:635. https://doi.org/10.1186/s12885-016-2672-8.

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     



  • Source link

    Related Articles